This content is from:Premium Tiger Cubs Poised to Benefit From This Covid-Related IPO AbCellera, which has developed a treatment for Covid-19, set terms this week for its IPO. ByStephen Taub December 08, 2020
This content is from:Premium These Companies Yielded a Big Payday for Viking Global Investors Two IPOs in which the Tiger Cub held sizable stakes surged in price, while another smaller biopharma stake has more than doubled since going public. ByStephen Taub December 14, 2020
This content is from:Premium An Under-the-Radar Hedge Fund Reaps Big IPO Rewards Bihua Chen’s Cormorant Asset Management is scoring big gains from development stage biopharma companies. ByStephen Taub December 17, 2020
This content is from:Premium Why Hedge Funds Love Health Care IPOs In recent months two companies with hedge fund ownership more than doubled, while several others are also up sharply. ByStephen Taub September 22, 2020
This content is from:Premium Tiger Global, Viking, Maverick Eye IPOs Citadel and Farallon are also gearing up for private holdings going public. ByStephen Taub November 24, 2020
This content is from:Premium Hedgies Eye IPOs Citadel and D1 Capital are among a slew of hedge funds gearing up for the latest health care initial public offerings. ByStephen Taub September 14, 2020
